Notch ligand-expressing adenovirus infection enhances the efficacy of dendritic cell-based immunotherapy for allergic asthma in mice

[1]  Jinfang Zhu,et al.  Orchestration between ILC2s and Th2 cells in shaping type 2 immune responses , 2019, Cellular & Molecular Immunology.

[2]  C. Fan,et al.  Jagged1‐expressing adenovirus‐infected dendritic cells induce expansion of Foxp3+ regulatory T cells and alleviate T helper type 2‐mediated allergic asthma in mice , 2018, Immunology.

[3]  W. Gerritsen,et al.  Dendritic Cell Cancer Therapy: Vaccinating the Right Patient at the Right Time , 2018, Front. Immunol..

[4]  Limin Chen,et al.  Construction and Characterization of Adenovirus Vectors Encoding Aspartate-β-Hydroxylase to Preliminary Application in Immunotherapy of Hepatocellular Carcinoma , 2018, Journal of immunology research.

[5]  Yueh-Lun Lee,et al.  Overexpression of Notch ligand Delta-like-1 by dendritic cells enhances their immunoregulatory capacity and exerts antiallergic effects on Th2-mediated allergic asthma in mice. , 2017, Clinical immunology.

[6]  C. Fan,et al.  Osthole treatment ameliorates Th2-mediated allergic asthma and exerts immunomodulatory effects on dendritic cell maturation and function , 2017, Cellular & Molecular Immunology.

[7]  D. El-Ghoneimy,et al.  The use of inhaled corticosteroids in pediatric asthma: update , 2016, The World Allergy Organization journal.

[8]  C. Helbig,et al.  Notch in T Cell Differentiation: All Things Considered. , 2015, Trends in immunology.

[9]  Jason V. Evans,et al.  Multivalent Forms of the Notch Ligand DLL-1 Enhance Antitumor T-cell Immunity in Lung Cancer and Improve Efficacy of EGFR-Targeted Therapy. , 2015, Cancer research.

[10]  R. Pawankar,et al.  Allergic diseases and asthma: a global public health concern and a call to action , 2014, The World Allergy Organization journal.

[11]  Luke M Johnson.  All Things Considered , 1951 .